Goodwill and Other Intangible Assets (Tables)

9 Months Ended

Mar. 29, 2014

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Goodwill [Table Text Block]

hanges in the carrying amount of goodwill, by reportable segment, were as follows (in millions):

	Consumer Healthcare			Nutritionals		Rx Pharma-ceuticals		API		Specialty Sciences		Total
Balance as of June 29, 2013	$	279.9		$	331.7	$	385.5	$	92.2	$	—	$	1,089.3
Business acquisitions	428.3			91.5		316.1		—		1,257.2		2,093.1
Purchase accounting adjustments	(1.9		)	—		1.3		—		—		(0.6		)
Currency translation adjustment	5.7			—		16.5		3.4		—		25.6
Balance as of March 29, 2014	$	712.0		$	423.2	$	719.4	$	95.6	$	1,257.2	$	3,207.4

Schedule of Finite and Indefinite-Lived Intangible Assets [Table Text Block]

Other intangible assets and related accumulated amortization consisted of the following (in millions):

	March 29, 2014				June 29, 2013
	Gross		Accumulated Amortization		Gross		Accumulated Amortization
Amortizable intangibles:
Distribution, license and supply agreements	$	6,324.3	$	120.0	$	192.7	$	28.9
Developed product technology/formulation and product rights	925.4		277.7		896.8		204.6
Customer relationships	370.9		91.0		358.2		72.4
Trademarks	47.6		4.9		12.7		4.2
Non-compete agreements	15.2		8.4		13.3		6.0
Total	7,683.4		502.0		1,473.7		316.1
Non-amortizable intangibles:
Trade names and trademarks	59.0		—		57.0		—
IPR&D	9.8		—		27.8		—
Total other intangible assets	$	7,752.2	$	502.0	$	1,558.5	$	316.1

Schedule of Intangible Assets, Future Amortization Expense [Table Text Block]

Fiscal Year	Amount
2014(1)	$	109.0
2015	442.0
2016	452.0
2017	449.0
2018	441.0

⁽¹⁾Reflects remaining three months of fiscal 2014.